In the dimorphic fungus Cad Chitin is a fibrous polymer off-1,4-N-acetylglucosamine that constitutes a major structural component of the cell wall of many species of fungi, including those species that are pathogenic in humans. Because chitin is not found in mammals and its biosynthesis is normally essential for the shape and viability of the fungal cell (1, 2), chitin synthesis is an attractive target for the design of antifungal drugs. The most common medical mycosis is caused by Candida albicans, which is a diploid organism with no sexual cycle. This fungus is capable ofdimorphic growth where growth can occur by unicellular budding or filamentous hyphal extension and branch formation (3). The hyphal cell wall has three to five times the chitin content of the yeast cell wall (4, 5) and the cells have up to 10 times the in vivo chitin synthase activity (6). Three genes encoding chitin synthases have been cloned and sequenced in C. albicans (7,8,37). Two encode chitin synthase zymogens (CHSI and CHS2), homologous to the CHS genes of Saccharomyces cerevisiae. The third chitin synthase gene, CHS3, is homologous to the S. cerevisiae CSD2 (9) gene (also called CALI) and is apparently the structural gene for an enzyme, which in S. cerevisiae, does not require proteolysis for its activity. Northern blot analysis of the C. albicans CHS genes showed that CHS2 mRNA levels were elevated in cells undergoing hyphal development, whereas the CHS1 mRNA was expressed only at low levels early in germ-tube formation (8).The role of each of the chitin synthase activities described in S. cerevisiae has been investigated by disrupting each of the relevant genes (for a review, see ref. 10). Gene disruptions are more difficult in C. albicans because the organism is constitutively diploid and because stable multiply marked strains are required for sequential gene disruptions. Sequential gene disruption of HEM3 of C. albicans has been achieved with two genetic markers (11), but host strains with sufficient markers for the disruption of more than one structural gene are not yet available. In this study, we employed the "ura-blaster" protocol originally described by Alani et al.(12) for use with S. cerevisiae, to disrupt all alleles of the hyphal-specific C. albicans CHS2 gene. This method allows the sequential disruption of target alleles. by using Ura3 auxotrophy as a single selectable marker. Because the selectable marker can be regenerated after the disruption of each allele, this method overcomes the need for multiply marked host strains and is, therefore, ideally suited for the analysis of families of genes such as the CHS genes in C. albicans. We show that the chs2 null mutant was still able to form germ tubes, albeit with a reduced chitin content compared with the isogenic wild-type parent. A prototrophic chs2-null mutant was still able to cause disease in normal and immunosuppressed mice and had a similar virulence to the parental CHS2 strain. A preliminary report of the construction of the Achs2::hisG null mutant has a...